August 2021

With Covid-19 vaccine programmes racing full steam ahead, we turn our attention to another vaccine debate, this time surrounding chickenpox. Although a safe and effective vaccine against the condition has been available since 1988 and is a common part of routine childhood vaccinations in the US, the UK Government has opted to forgo the treatment. But why is this? In the next issue of Pharma Technology Focus, we find out.

Also, we unpack the research behind Swiss pharma firm Ferring Pharmaceuticals’ potential microbiome breakthrough, explore the history of ALS treatments and examine the potential consequences facing manufacturers if a proposed vaccine patent waiver becomes a reality.

Plus, we learn more about the fight to combat black fungus in India as manufacturers in the country race to develop anti-fungal drugs amid growing case numbers, find out how light-sensing algae proteins are being used in a standout therapy for sight impairment and get the latest insight and analysis from GlobalData.


Editor | Eloise McLennan

Writers | Abi Millar, Chloe Kent, Natalie Healey, Darcy Jimenez, Eric Caugant, Judi Sills
Magazine Designer | Marzia Del Gaone

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova, Dimeji Akinkuolie, Will Ingham
Lead Designer | John Hammond 

Publisher | Susanne Hauner
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.